Trials / Completed
CompletedNCT04202614
Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 58 (actual)
- Sponsor
- IRCCS San Raffaele · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The clinical and derived data from the preoperative computed axial tomography (CT) and Positron Emission Tomography (PET) of patients with pathological stage I pulmonary adenocarcinoma will be analyzed retrospectively, classified according to the current pathological classification IASLC / ATS / ERS of pulmonary adenocarcinoma, subjected to surgical treatment in our Operating Unit between August 2006 and July 2011. A follow-up will be performed on the patients enrolled in the study up to the date of death, and in any case no later than October 31, 2019
Conditions
Timeline
- Start date
- 2019-12-02
- Primary completion
- 2020-01-31
- Completion
- 2020-01-31
- First posted
- 2019-12-17
- Last updated
- 2021-02-10
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04202614. Inclusion in this directory is not an endorsement.